Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance

  • Clare C. Walsh
  • , Cornelia B. Landersdorfer
  • , Michelle P. McIntosh
  • , Anton Y. Peleg
  • , Elizabeth B. Hirsch
  • , Carl M. Kirkpatrick
  • , Phillip J. Bergen

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Veterinary Science and Veterinary Medicine